InsiderTrades

Form 4 for INSM INSMED Inc

Accepted 2023-12-22 00:00:00 ET · period of report 2023-12-22 · accession 0001628280-23-042631 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-12-22 2023-12-22 INSM Flammer Martina M.D. Chief Medical Off S - Sale+OE $30.00 -28.3K 106.0K -21% -$849.3K
D 2023-12-22 2023-12-22 INSM Flammer Martina M.D. Chief Medical Off M - OptEx $23.66 +28.3K 134.3K +27% +$669.8K
D 2023-12-22 2023-12-22 INSM Flammer Martina M.D. Chief Medical Off M - OptEx $0.00 -28.3K 122.7K -19% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-12-22 S D 28,310 $30.00 106,038 D — —
2 Common Common Stock 2023-12-22 M A 28,310 $23.66 134,348 D — —
3 Derivative Stock Option (right to buy) 2023-12-22 M D 28,310 $0.00 122,680 D $23.66 · — to 2030-01-02 28,310 Common Stock (F2) In connection with the appointment of Dr. Flammer as the Company's Chief Medical Officer, the Company granted Dr. Flammer an option to purchase a total of 150,990 shares of the Company's common stock. The option becomes exercisable based on the following vesting schedule: twenty-five percent (25%) vest on the first anniversary of the date of grant and twelve and one-half percent (12.5%) vest on each six month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Dr. Flammer's continued employment with the Company on each vesting date.